Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03649490 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Advanced Materials Science in XLIF Study

Study acronym: AMS in XLIF
StatusEnrolling by Invitation
PhaseNot specified
SponsorNuVasive
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 22, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 1, 2024 to Jun 30, 2026
    • Study completion date: Dec 1, 2025 to Dec 31, 2026
    v12
  2. 2 versions Re-verified since May 2, 2024, no change to tracked fieldsv10-v11
  3. Study sites: 14 to 15
    • Primary completion date: Aug 1, 2024 to Dec 1, 2024
    • Study completion date: Aug 1, 2024 to Dec 1, 2025
    v9
  4. Study sites: 12 to 14v8
  5. Study sites: 11 to 12v7
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites revised (11)v6
  2. Primary and study completion dates: Aug 1, 2022 to Aug 1, 2024
    • Study sites: 9 to 11
    • Eligibility criteria expanded, about 86 words
    v5
  3. Study sites: 8 to 9
    • Interventions: Extreme Lateral Interbody Fusion (Procedure) to not stated
    • Eligibility criteria shortened, about 18 words
    v4
  4. Study sites: 6 to 8
    • Eligibility criteria expanded, about 58 words
    • Secondary endpoints: details revised at 2 of 4 entries
    v3
  5. Study sites: 5 to 6
    • Eligibility criteria shortened, about 4 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
NuVasive
13 trials monitored
See all monitored trials
This study is being conducted to evaluate the clinical and radiographic outcomes of three different interbody implant types when used with cancellous allograft chips with BMA or cellular allograft in patients undergoing XLIF surgery. The study will evaluate success by comparing the rate of fusion, complications profile, and any relationships between clinical outcomes (pain and function) and radiographic outcomes (fusion rate) between the three implant groups.
Trial Details
NCT Number NCT03649490
Lead Sponsor NuVasive
Conditions
(from sponsor)		 Degenerative Disc Disease, Spondylolisthesis
Related terms Intervertebral Disc Degeneration, Spondylolisthesis
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov